Cargando…

Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making

Kidney transplant recipients (KTRs) have increased incidence of de novo cancers. After having undergone treatment for cancer with curative intent, reducing the overall immunosuppressive load and/or switching to an alternative drug regimen may potentially be of great benefit to avoid cancer recurrenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hellemans, Rachel, Pengel, Liset H.M., Choquet, Sylvain, Maggiore, Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews in Clinical Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518116/ https://www.ncbi.nlm.nih.gov/pubmed/34146426 http://dx.doi.org/10.1111/tri.13952

Ejemplares similares

Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same?
por: Melilli, Edoardo, et al.
Publicado: (2018)

COVID-19 AND IMMUNOSUPPRESSION: A CASE OF COVID-19 IN A RENAL TRANSPLANT RECIPIENT
por: Boparai, Sukhmani, et al.
Publicado: (2020)

EXCELLENT ALLOGRAFT RECOVERY DESPITE PROLONGED SARS-COV-2 SHEDDING AFTER REDUCTION OF IMMUNOSUPPRESSION IN LUNG TRANSPLANT RECIPIENT
por: RAZIA, DEEPIKA, et al.
Publicado: (2021)

Influence of broader geographic allograft sharing on outcomes and cost in smaller lung transplant centers
por: Haywood, Nathan, et al.
Publicado: (2020)

Indexed donor cardiac output for improved size matching in heart transplantation: A United Network for Organ Sharing database analysis
por: Pasrija, Chetan, et al.
Publicado: (2023)

Renal Outcomes of Liver Transplantation Recipients Receiving Standard Immunosuppression and Early Renal Sparing Immunosuppression: A Retrospective Single Center Study
por: Sharma, Pratima, et al.
Publicado: (2019)

Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and Retransplantation
por: Balakrishnan, Suryanarayanan, et al.
Publicado: (2022)

Pretransplant Donor-specific IFNγ ELISPOT as a Predictor of Graft Rejection: A Diagnostic Test Accuracy Meta-analysis
por: Montero, Nuria, et al.
Publicado: (2019)

Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology
por: Lorenz, Elizabeth C., et al.
Publicado: (2018)

Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis
por: Wehmeier, Caroline, et al.
Publicado: (2017)

The First Collective Examination of Immunosuppressive Practices Among American Intestinal Transplant Centers
por: Weiner, Joshua, et al.
Publicado: (2023)

Statistical guidance for responsible data sharing: an overview
por: Fletcher, Christine, et al.
Publicado: (2016)

The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant
por: Nimmo, Ailish M. S. A., et al.
Publicado: (2018)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Does the Tacrolimus Trough Level Adequately Predict Drug Exposure in Patients Requiring a High Tacrolimus Dose?
por: Haverals, Lien, et al.
Publicado: (2023)

Immunosuppressive Effects of Streptozotocin-Induced Diabetes Result in Absolute Lymphopenia and a Relative Increase of T Regulatory Cells
por: Muller, Yannick D., et al.
Publicado: (2011)

Reliability and Validity of the Japanese Version of the Basel Assessment of Adherence to Immunosuppressive Medications Scale in Kidney Transplant Recipients
por: Kosoku, Akihiro, et al.
Publicado: (2023)

The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Post-renal Transplantation Patients
por: Smith, Aaron, et al.
Publicado: (2017)

COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience
por: Maurer, Katie, et al.
Publicado: (2021)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

Preexisting Autoantibodies Predict Efficacy of Oral Insulin to Cure Autoimmune Diabetes in Combination With Anti-CD3
por: Mamchak, Alusha A., et al.
Publicado: (2012)

Identical Twin Small-bowel Transplantation Without Maintenance Immunosuppression: A 5-year Follow-up and Literature Review
por: Wu, Guosheng, et al.
Publicado: (2018)

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study
por: Bottomley, Matthew J., et al.
Publicado: (2016)

Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid
por: Satapathy, Sanjaya K., et al.
Publicado: (2017)

ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities
por: Shagrani, Mohammad, et al.
Publicado: (2022)

Pre-emptive living donor kidney transplantation: A public health justification to change the default
por: Kim, Isaac, et al.
Publicado: (2023)

Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis
por: Nazzal, Mustafa, et al.
Publicado: (2018)

Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
por: van Sandwijk, Marit S., et al.
Publicado: (2018)

A Pilot Study of Postoperative Animal Welfare as a Guidance Tool in the Development of a Kidney Autotransplantation Model With Extended Warm Ischemia
por: Lohmann, Stine, et al.
Publicado: (2019)

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
por: Abedini, Sadollah, et al.
Publicado: (2018)

Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
por: Busque, Stephan, et al.
Publicado: (2018)

Medication, Healthcare Follow-up, and Lifestyle Nonadherence: Do They Share the Same Risk Factors?
por: Ng, Yue-Harn, et al.
Publicado: (2021)

UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center
por: Kurian, Sunil M., et al.
Publicado: (2021)

Pediatric Outcomes in Transplant: PersOnaliSing Immunosuppression To ImproVe Efficacy (POSITIVE Study): The Collaboration and Design of a National Transplant Precision Medicine Program
por: Papaz, Tanya, et al.
Publicado: (2018)

Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study
por: Friman, Styrbjörn, et al.
Publicado: (2021)

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study
por: Pernin, Vincent, et al.
Publicado: (2023)

Management of Bilateral Ureteral Obstruction After Transplantation of Pediatric En Bloc Kidneys, a Case Report and Review of Available Literature
por: Allam, Sridhar R., et al.
Publicado: (2019)

Simultaneous Islet and Kidney Transplantation in Seven Patients With Type 1 Diabetes and End-Stage Renal Disease Using a Glucocorticoid-Free Immunosuppressive Regimen With Alemtuzumab Induction
por: Tan, Jianming, et al.
Publicado: (2008)

Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen
por: Phirom, Supitchaya, et al.
Publicado: (2022)

Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?
por: Maggiore, Umberto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i08g2j001des80osiru8i4agqe